vs
CREDIT ACCEPTANCE CORP（CACC）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是CREDIT ACCEPTANCE CORP的1.2倍（$702.9M vs $579.9M），Healthpeak Properties净利率更高（51.6% vs 21.0%，领先30.6%），CREDIT ACCEPTANCE CORP同比增速更快（2.5% vs -6.6%），过去两年CREDIT ACCEPTANCE CORP的营收复合增速更高（6.8% vs 0.5%）
Credit Acceptance是一家汽车金融服务提供商，主要提供汽车贷款及相关金融产品。公司通过覆盖全国的合作汽车经销商网络开展业务，设有“投资组合计划”和“采购计划”两大业务项目，可向汽车经销商提供资金，以此换取对应消费者贷款的后续服务权利。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CACC vs DOC — 直观对比
营收规模更大
DOC
是对方的1.2倍
$579.9M
营收增速更快
CACC
高出9.1%
-6.6%
净利率更高
DOC
高出30.6%
21.0%
两年增速更快
CACC
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $579.9M | $702.9M |
| 净利润 | $122.0M | $363.0M |
| 毛利率 | — | — |
| 营业利润率 | 27.1% | 0.7% |
| 净利率 | 21.0% | 51.6% |
| 营收同比 | 2.5% | -6.6% |
| 净利润同比 | -19.7% | 28.3% |
| 每股收益（稀释后） | $10.87 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CACCDOC
| Q1 26 | — | $702.9M | ||
| Q4 25 | $579.9M | $719.4M | ||
| Q3 25 | $582.4M | $705.9M | ||
| Q2 25 | $583.8M | $694.3M | ||
| Q1 25 | $571.1M | $702.9M | ||
| Q4 24 | $565.9M | $698.0M | ||
| Q3 24 | $550.3M | $700.4M | ||
| Q2 24 | $538.2M | $695.5M |
净利润CACCDOC
| Q1 26 | — | $363.0M | ||
| Q4 25 | $122.0M | $114.0M | ||
| Q3 25 | $108.2M | $-117.1M | ||
| Q2 25 | $87.4M | $31.7M | ||
| Q1 25 | $106.3M | $42.8M | ||
| Q4 24 | $151.9M | $4.5M | ||
| Q3 24 | $78.8M | $85.9M | ||
| Q2 24 | $-47.1M | $146.0M |
毛利率CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 61.1% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | — | 60.6% |
营业利润率CACCDOC
| Q1 26 | — | 0.7% | ||
| Q4 25 | 27.1% | 17.4% | ||
| Q3 25 | 25.6% | 9.2% | ||
| Q2 25 | 20.2% | 5.7% | ||
| Q1 25 | 24.8% | 7.7% | ||
| Q4 24 | 33.9% | -2.2% | ||
| Q3 24 | 19.4% | 14.1% | ||
| Q2 24 | -10.3% | 22.3% |
净利率CACCDOC
| Q1 26 | — | 51.6% | ||
| Q4 25 | 21.0% | 73.2% | ||
| Q3 25 | 18.6% | -16.6% | ||
| Q2 25 | 15.0% | 4.6% | ||
| Q1 25 | 18.6% | 6.1% | ||
| Q4 24 | 26.8% | 0.7% | ||
| Q3 24 | 14.3% | 12.3% | ||
| Q2 24 | -8.8% | 21.0% |
每股收益（稀释后）CACCDOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | $10.87 | $0.16 | ||
| Q3 25 | $9.43 | $-0.17 | ||
| Q2 25 | $7.42 | $0.05 | ||
| Q1 25 | $8.66 | $0.06 | ||
| Q4 24 | $12.28 | $0.02 | ||
| Q3 24 | $6.35 | $0.12 | ||
| Q2 24 | $-3.83 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.8M | $-1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $7.8B |
| 总资产 | $8.6B | $21.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CACCDOC
| Q1 26 | — | $-1.2B | ||
| Q4 25 | $22.8M | $467.5M | ||
| Q3 25 | $15.9M | $91.0M | ||
| Q2 25 | $70.0M | $89.4M | ||
| Q1 25 | $528.8M | $70.6M | ||
| Q4 24 | $343.7M | $119.8M | ||
| Q3 24 | $159.7M | $180.4M | ||
| Q2 24 | $8.3M | $106.9M |
总债务CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益CACCDOC
| Q1 26 | — | $7.8B | ||
| Q4 25 | $1.5B | $7.5B | ||
| Q3 25 | $1.6B | $7.6B | ||
| Q2 25 | $1.6B | $7.9B | ||
| Q1 25 | $1.7B | $8.2B | ||
| Q4 24 | $1.7B | $8.4B | ||
| Q3 24 | $1.6B | $8.6B | ||
| Q2 24 | $1.6B | $8.8B |
总资产CACCDOC
| Q1 26 | — | $21.6B | ||
| Q4 25 | $8.6B | $20.3B | ||
| Q3 25 | $8.6B | $19.6B | ||
| Q2 25 | $8.7B | $19.8B | ||
| Q1 25 | $9.3B | $19.8B | ||
| Q4 24 | $8.9B | $19.9B | ||
| Q3 24 | $8.7B | $20.0B | ||
| Q2 24 | $8.3B | $20.2B |
负债/权益比CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $269.3M | — |
| 自由现金流经营现金流 - 资本支出 | $268.9M | — |
| 自由现金流率自由现金流/营收 | 46.4% | — |
| 资本支出强度资本支出/营收 | 0.1% | 3.4% |
| 现金转化率经营现金流/净利润 | 2.21× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | $269.3M | $1.3B | ||
| Q3 25 | $299.4M | $315.0M | ||
| Q2 25 | $139.7M | $363.5M | ||
| Q1 25 | $346.2M | $279.4M | ||
| Q4 24 | $306.2M | $1.1B | ||
| Q3 24 | $317.7M | $318.2M | ||
| Q2 24 | $204.0M | $316.2M |
自由现金流CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | $268.9M | $357.0M | ||
| Q3 25 | $298.8M | — | ||
| Q2 25 | $139.4M | — | ||
| Q1 25 | $345.9M | — | ||
| Q4 24 | $305.5M | $333.7M | ||
| Q3 24 | $317.3M | — | ||
| Q2 24 | $203.6M | — |
自由现金流率CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | 46.4% | 49.6% | ||
| Q3 25 | 51.3% | — | ||
| Q2 25 | 23.9% | — | ||
| Q1 25 | 60.6% | — | ||
| Q4 24 | 54.0% | 47.8% | ||
| Q3 24 | 57.7% | — | ||
| Q2 24 | 37.8% | — |
资本支出强度CACCDOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | 0.1% | 124.4% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | 105.6% | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — |
现金转化率CACCDOC
| Q1 26 | — | — | ||
| Q4 25 | 2.21× | 10.99× | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 1.60× | 11.48× | ||
| Q1 25 | 3.26× | 6.52× | ||
| Q4 24 | 2.02× | 235.43× | ||
| Q3 24 | 4.03× | 3.71× | ||
| Q2 24 | — | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CACC
| Loans Receivable | $553.0M | 95% |
| Other | $26.9M | 5% |
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
